← Leaderboards
Michael J. Dawson
$5,928,021
Attributed
$5,928,021
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2M · FY2015–19$2.5M$1.9M$1.3M$625K$0
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$5,928,021 · 1
By mechanism
N01$5,928,021 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Toxic Effect”
- George R Seage · Abt Associates, Inc.$224,114,540
- Peter C Adamson · National Childhood Cancer Foundation$126,756,857
- Gregory H Reaman · National Childhood Cancer Foundation$123,836,183
- Carol Nesel · Westat$116,355,411
- Mary M Horowitz · Medical College Of Wisconsin$90,165,506
- Barney Sparrow · Battelle Memorial Institute$88,494,220
Research focus
Toxic EffectKlebsiella Pneumonia BacteriumLeadPharmaceutical ChemistryPre-ClinicalPseudomonas AeruginosaSeriesSmall MoleculeTherapeutic DevelopmentAcinetobacter BaumanniiBacterial ResistanceCarbapenem-Resistant EnterobacteriaceaeCommunicable DiseasesDrug CandidateFutureInfectious Disease TreatmentIn VitroPathogenAntimicrobial ResistanceIn VivoClinical DevelopmentTherapeutic Lead CompoundIn Vivo EvaluationStaging
Grant awards (5)
Optimizing Lead Therapeutic Compounds Against Infectious Diseases$210,895
N01 · FY2019 · AI · contact PI
Optimizing Lead Therapeutic Compounds Against Infectious Diseases$571,132
N01 · FY2018 · AI · contact PI
Optimizing Lead Therapeutic Compounds Against Infectious Diseases$2,015,511
N01 · FY2017 · AI · contact PI
Optimizing Lead Therapeutic Compounds Against Infectious Diseases$1,634,580
N01 · FY2016 · AI · contact PI
Optimizing Lead Therapeutic Compounds Against Infectious Diseases$1,495,903
N01 · FY2015 · AI · contact PI